INVO Fertility EPS IVF
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- n/m
- a quarter missing
- Latest quarter, Q2 FY26
- $1.40
- Fiscal year 2024
- −$13560.00
INVO Fertility's twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.
In its latest quarter, Q2 FY26, it was $1.40.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2024 | −$13560.00 | n/a |
| FY2023 | −$48960.00 | n/a |
| FY2022 | −$103449.60 | n/a |
| FY2021 | −$77184.00 | n/a |
| FY2020 | −$167040.00 | n/a |
| FY2019 | −$41241.60 | n/a |
| FY2018 | −$73728.00 | n/a |
| FY2017 | $0.00 | n/a |
| FY2016 | −$36864.00 | n/a |
| FY2015 | −$147456.00 | n/a |
| FY2014 | n/a | n/a |
| FY2013 | n/a | n/a |
| FY2012 | n/a | n/a |
| FY2011 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $1.40 | n/a | n/a | |
| Q1 FY26 | −$13.52 | n/a | n/a | |
| Q3 FY25 | −$123.20 | n/a | −$19411.84 | |
| Q2 FY25 | −$1456.92 | n/a | −$21706.24 | |
| Q1 FY25 | −$13895.72 | n/a | −$23831.72 | |
| Q4 FY24 | −$3936.00 | n/a | −$13560.00 | |
| Q3 FY24 | −$2417.60 | n/a | −$13310.40 | |
| Q2 FY24 | −$3582.40 | n/a | −$14924.80 | |
| Q1 FY24 | −$3624.00 | n/a | −$28968.00 | |
| Q4 FY23 | −$3686.40 | n/a | −$48960.00 | |
| Q3 FY23 | −$4032.00 | n/a | −$71481.60 | |
| Q2 FY23 | −$17625.60 | n/a | −$91584.00 |
Against its peers
Companies in Medical - Instruments & Supplies nearest INVO Fertility's size, closest first, today.
| Company | EPS, 12 months |
|---|---|
| IVFINVO Fertility | n/m |
| BBLGBone Biologics | −$1.41 |
| TNONTenon Medical | −$25.65 |
| VJETFlyte Aviation | n/m |
| AMIXAutonomix Medical | n/m |
| NXGLNexgel | −$14.20 |
| ADGMAdagio Medical | −$1.43 |
| XAIRBeyond Air | −$68.40 |
| VVOSVivos Therapeutics | −$1.88 |
| CODXCo-Diagnostics | −$24.03 |
| BJDXBluejay Diagnostics | −$34.72 |
| Peer median | −$19.11 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on INVO Fertility
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.